Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone and Misoprostol Versus Misoprostol Alone for Treatment of Fetal Death
NCT02633761Phase 3Terminated
- Sponsor
- Gynuity Health Projects
- Start
- Apr 2015
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of mifepristone in fetal death (IUFD) (2 arms), sponsored by Gynuity Health Projects. Primary endpoint: Complete uterine evacuation of the fetus and placenta without surgical intervention at 48 hours. Started Apr 2015; status: terminated.
02
Drugs
mifepristone
03
Conditions
fetal death (IUFD)
Beyond the preview
Go deeper on NCT02633761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02633761.